Somnigroup EVP granted 9,015 performance stock units
Somnigroup International Inc. reported that EVP Global Business Strategy David Montgomery received a grant of 9,015 performance restricted stock units at no cash cost.
Rhea-AI Filing Summary
Somnigroup International Inc. reported that EVP Global Business Strategy David Montgomery received a grant of 9,015 performance restricted stock units at no cash cost. These units can pay out from 0% to 300% of the target based on adjusted EPS, adjusted EBITDA and strategic initiatives results.
The compensation committee set the final payout on February 26, 2026, resulting in the 9,015 performance shares reported. The PRSUs are scheduled to vest in roughly three equal installments on January 4, 2027, 2028 and 2029, and each unit converts into one share of common stock upon settlement.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Restricted Stock Units | 9,015 | $0.00 | $0.00 |
Footnotes (2)
- F1. Performance restricted stock units and restricted stock units convert into common stock on a one-for-one basis.
- F2. On January 3, 2025, the reporting person was granted a target number of performance shares, with the payout from 0 to 300% of target based on the Company's adjusted EPS, adjusted EBITDA and qualitative Strategic Initiatives performance. The Human Resources/Capital and Talent Committee of the Board of Directors determined the payout for each metric on February 26, 2026 resulting in the reported number of performance shares received. The PRSUs vest in approximately three equal installments on January 4, 2027, 2028 and 2029.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Somnigroup (SGI) report for David Montgomery?
How many performance restricted stock units did SGI grant in this Form 4?
When do David Montgomery’s Somnigroup (SGI) PRSUs vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.